We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
ImClone Systems suffered a major legal defeat when a U.S. district judge ruled that three Israeli scientists actually invented the cancer treatment the company sells under the trade name Erbitux.
The United Nations and French officials yesterday officially launched UNITAID, the International Drug Purchase Facility, which will be led by France, Norway and the UK, among others.
AnorMED Inc. announced that under the terms of an existing agreement, AnorMED will receive a U.S.$3 million milestone payment from Shire Pharmaceuticals Group, plc based on the recent licensing approval received in Germany by Shire to sell FOSRENOL as a treatment for high phosphate levels in the blood, which occurs in patients undergoing dialysis as a result of chronic kidney failure.
US-based Inovio Biomedical Corporation, late stage developer of therapies for cancer and other applications using electroporation to deliver drugs and nucleic acids, will establish Inovio Asia Pte Ltd., a majority-owned subsidiary in the Republic of Singapore, with the goal of pursuing business and scientific development opportunities in the east Asian marketplace.
The Asia-Pacific region is still not prepared to handle the threat from emerging infectious diseases such as bird flu, according to the World Health Organization (WHO).
The U.S. Bioshield program to protect citizens from a biological attack with drugs is being hobbled by drug companies' lobbying, The New York Times reports.
AnorMED Inc. today announced it will receive U.S. $10 million in cash in consideration for amending the license agreement for its proprietary anti-cancer drug picoplatin (NX473) to expand the licensed territories to worldwide, forego future development milestones and reduce royalty payments.
Ethypharm India, subsidiary of leading French multinational Drug Delivery Company Ethypharm SA, has signed out-licensing and supply contract agreements for a Fixed Dose Combination of Fenofibrate micronized 160 mg and Atorvastatin 10 mg with Ranbaxy, based out of India, which will be launched in the Indian market.
A donation of drugs worth $1.6 million from the European Union (EU) and the United Nations Children's Fund (UNICEF) will benefit 890,000 children and 32,000 pregnant women in Burundi over the next three months.